Can gut dysbiosis alter estrogen cycling without elevated stool beta-glucuronidase?

Mechanistic pathways of estrogen reactivation

• Enzymatic diversity: Beyond the classic beta-glucuronidase pathway, the gut microbiota produces alternative enzymes that process estrogens. Key among these are bacterial steroid sulfatases (STS) and hydroxysteroid dehydrogenases, specifically 3β-hydroxysteroid dehydrogenase (3β-HSD) and 17β-HSD.
• Taxonomic shifts: Gut dysbiosis alters the abundance of sulfatase-positive bacterial taxa—such as Collinsella, Escherichia, Bacteroides, Alistipes, Hungatella, and Peptococcus—directly modulating microbial sulfatase capacity.
• Metabolite conversion: Bacterial sulfatases hydrolyze estrone sulfate (E1S), the most abundant biliary estrogen conjugate, back into active free estrone. Meanwhile, HSDs directly interconvert active estradiol and estrone within the gut lumen.

Impact on enterohepatic cycling and systemic exposure

• Mucosal reabsorption: Deconjugated, free estrogens generated via sulfatase and HSD pathways are readily reabsorbed across the intestinal mucosa.
• Systemic return: Once reabsorbed, these free estrogens enter the portal vein to return to the systemic circulation instead of being excreted in the stool.
• Independent modulation: This mechanism alters systemic estrogen exposure and can drive estrogen-sensitive clinical phenotypes even in the absence of elevated fecal beta-glucuronidase.

Bottom line

• Gut dysbiosis alters systemic estrogen exposure independently of beta-glucuronidase by utilizing bacterial sulfatases and hydroxysteroid dehydrogenases to reactivate and reabsorb biliary estrogen conjugates.